Itraconazole maintenance treatment for histoplasmosis in AIDS: A prospective, multicenter trial

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 2, 1997, Pages 100-107

  Hecht, Frederick M ^a,q   Wheat, Joseph ^b,c   Korzun, Ann H ^d   Hafner, Richard ^e   Skahan, Kenneth J ^f   Larsen, Robert ^g   Limjoco, Maria Theresa ^d   Simpson, Margaret ^h   Schneider, Debra ⁱ   Keefer, Michael C ^j   Clark, Rebecca ^k   Lai, Kwan Kew ^l   Jacobson, Jeffrey M ^m   Squires, Kathleen ⁿ   Bartlett, John A ^o   Powderly, William ^p  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Cardiovascular Data Analysis Center   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^j UNIVERSITY OF ROCHESTER   (United States)

^k TULANE UNIVERSITY   (United States)

^l UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^m MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁿ Department of Obstetrics Gynecology   (United States)

^o DUKE UNIVERSITY   (United States)

^p WASHINGTON UNIVERSITY   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

AIDS; Clinical trial; Histoplasmosis; Itraconazole

Indexed keywords

FUNGUS ANTIGEN; ITRACONAZOLE; POLYSACCHARIDE; RIFAMPICIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; FEVER; HISTOPLASMOSIS; HUMAN; LIVER TOXICITY; MAINTENANCE THERAPY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; RELAPSE; SURVIVAL;

AJELLOMYCES; FUNGI;

EID: 12644262391     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199710010-00005     Document Type: Article

References (26)

1. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 1990;69:361-74.
2. Negroni R, Robles AM, Arechavala A, Taborda A. Itraconazole in human histoplasmosis. Mycoses 1989;32:123-30.
3. Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med 1995;98:336-42.
4. Wheat J, Hafner R, Wulfsohn M, et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. The National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators. Ann Intern Med 1993;118:610-6.
5. Fromtling RA, Galgiani JN, Pfaller MA, et al. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother 1993;37:39-45.
6. Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med 1986;314:83-8.
7. Wheat LJ, Connolly-Stringfield P, Kohler RB, Frame PT, Gupta MR. Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1989; 87:396-400.
8. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
9. Kalbfleisch J, Prentice R. The statistical analysis of failure time data. New York: John Wiley and Sons, 1980.
10. Johnson PC, Khardori N, Najjar AF, Butt F, Mansell PW, Sarosi GA. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:152-8.
11. McKinsey DS, Gupta MR, Driks MR, Smith DL, O'Connor M. Histoplasmosis in patients with AIDS: efficacy of maintenance amphotericin B therapy. Am J Med 1992;92:225-7.
12. McKinsey DS, Gupta MR, Riddler SA, Driks MR, Smith DL, Kurtin PJ. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;111:655-9.
13. Norris S, Wheat J, McKinsey D, et al. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. Am J Med 1994;96:504-8.
14. Sharkey-Mathis PK, Velez J, Fetchick R, Graybill JR. Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole. J Acquir Immune Defic Syndr 1993;6:809-19.
15. Chuck S, Sande M. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321:794-9.
16. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C. A controlled trial of trimethoprim-sulfamethoxoazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;327:1842-8.
17. Wheat LJ, Connolly-Stringfield P, Blair R, Connolly K, Garringer T, Katz BP. Histoplasmosis relapse in patients with AIDS: detection using Histoplasmosis capsulatum variety capsulation antigen levels. Ann Intern Med 1991;115:936-41.
18. Drayton J, Dickinson G, Rinaldi MG. Coadministration of n-fampin and itraconazole leads to undetectable levels of serum itraconazole. Clin Infect Dis 1994;18:266.
19. Knight TE, Shikuma CY, Knight J. Ketoconazole-induced fulminant hepatitis necessitating liver transplantation. J Am Acad Dermatol 1991;25:398-400.
20. Stricker BH, Blok AP, Bronkhorst FB, Van Parys GE, Desmet VJ. Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases. J Hepatol 1986;3:399-406.
21. Pariser DM, Pariser RJ, Ruoff G, Ray TL. Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris. J Am Acad Dermatol 1994;31:232-4.
22. Wishart JM. A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus. N Z. Med J 1994; 107: 126-8.
23. Korting HC, Schafer-Korting M, Zienicke H, Georgii A, Ollert MW. Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. Antimicrob Agents Chemother 1993;37:2064-8.
24. Hann SK, Kim JB, Im S, Han KH, Park YK. Itraconazole-induced acute hepatitis. Br J Dermatol 1993;129:500-1.
25. Lavrijsen AP, Balmus KJ, Nugteren-Huying WM, Roldaan AC, van't Wout JW, Stricker BH. Hepatic injury associated with itraconazole. Lancet 1992;340:251-2.
26. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994;330:263-72.